IP Library Granted Patent US 12,399,185
Granted Patent B2
US 12,399,185 · App. 18/668,683 · Granted Aug 26, 2025

Apparatus for measuring glycation of red blood cells and glycated hemoglobin level using physical and electrical characteristics of cells, and related methods

Inventors: Ung Hyeon Ko (Seoul, KR); Seung Jin Kang (Seoul, KR); Eun Young Park (Seoul, KR)
Assignee: ORANGE BIOMED CO., LTD.
G01N33/726B01L3/502715G01N33/49G01N33/723G01N33/80B01L2200/027B01L2200/10B01L2200/14B01L2300/0645B01L2300/0816B01L2300/087B01L2400/0403
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,399,185
App. No.
18/668,683
Granted
Aug 26, 2025
Kind
B2
Abstract

The present disclosure relates to systems and methods for measuring glycated A1c hemoglobin. A glycated hemoglobin level measuring system includes a sample testing apparatus having a microchannel that compresses a blood sample traveling through, a first pair of electrodes coupled to the microchannel, and a second pair of electrodes coupled to the microchannel. The glycated hemoglobin level measuring system further includes an analysis apparatus having sensors coupled to the first and second pairs of electrodes and configured to calculate a travel time taken by a red blood cell to pass through the first and second pairs of electrodes. The glycated hemoglobin level measuring system can use the travel time to measure a rigidity of the red blood cells and the corresponding glycated hemoglobin level.

Claims (14)

1. A glycated hemoglobin level measuring system, comprising:

a sample testing apparatus that includes:

a substrate having thereon a microchannel connected between an inlet and an outlet, wherein the inlet is configured to receive blood sample with red blood cells suspended therein, wherein the microchannel is configured to transfer the blood sample from the inlet to the outlet, and wherein the microchannel has a width that is less than an average diameter of the red blood cells for compressing the red blood cells;

a first pair of electrodes on or embedded in the substrate, coupled to the microchannel, and spaced along the microchannel so as to define a first detection region between the first pair of electrodes; and

a second pair of electrodes on or embedded in the substrate and coupled to the microchannel between the first pair of electrodes and the outlet, wherein the second pair of electrodes are spaced along the microchannel so as to define a second detection region between the second pair of electrodes.

2. The glycated hemoglobin level measuring system of claim 1 , wherein the inlet, the outlet, or both are configured to couple to a pump configured to facilitate a transfer of the blood sample through the microchannel from the inlet to the outlet.

3. The glycated hemoglobin level measuring system of claim 1 , wherein the width of the microchannel is less than 8 micrometers for compressing the red blood cells passing through the microchannel.

4. The glycated hemoglobin level measuring system of claim 1 , wherein a height of the microchannel is less than 3 micrometers for compressing the red blood cells passing through the microchannel.

5. The glycated hemoglobin level measuring system of claim 1 , wherein a length of the first detection region along the microchannel is less than 25 micrometers.

6. The glycated hemoglobin level measuring system of claim 1 , wherein a distance between the first and second pairs of electrodes is between 300 micrometers and 800 micrometers.

7. The glycated hemoglobin level measuring system of claim 1 , wherein the sample testing apparatus further includes an electrolyte in the inlet, the microchannel, or both, the electrolyte configured to mix with the blood sample and provide an initial impedance level across the first pair of electrodes and across the second pair of electrodes.

8. The glycated hemoglobin level measuring system of claim 1 , wherein the width of the microchannel and the first and second pairs of electrodes are configured for detecting travel times of the red blood cells through the microchannel between the first and second pairs of electrodes, wherein the travel times are representative of a glycated hemoglobin level of the red blood cells.

9. The glycated hemoglobin level measuring system of claim 1 , wherein the first and second pairs of electrodes are configured to couple to a logic configured to calculate a time difference representing a travel period of one of the red blood cells between the first and second detection regions.

10. The glycated hemoglobin level measuring system of claim 1 , wherein the sample testing apparatus is reusable.

Assignments (2)
CHANGE OF NAME Recorded Sep 13, 2024
From: ORANGE BIOMED LTD., CO.
To: ORANGE BIOMED CO., LTD.
Reel/Frame 069198/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2024
From: KO, UNG HYEON; KANG, SEUNG JIN; PARK, EUN YOUNG
To: ORANGE BIOMED LTD., CO.
Reel/Frame 067685/0778 →
Priority Claims (1)
KR 10-2021-0128520 · Sep 29, 2021 · national
Continuity (4)
Division 18364436 · Aug 2, 2023
Division 18064233 · Dec 9, 2022
Continuation In Part PCTKR2021018280 · Dec 3, 2021
Related Publication 20240310390A1 · Sep 19, 2024
References Cited (71)
US 5206144A · Zeuthen et al. · 1993 [cited by applicant]
US 5642734A · Ruben et al. · 1997 [cited by applicant]
US 6204668B1 · Sequeira et al. · 2001 [cited by applicant]
US 6399293B1 · Pachl et al. · 2002 [cited by applicant]
US 6949070B2 · Ishler · 2005 [cited by applicant]
US 8252163B2 · Sugiyama et al. · 2012 [cited by applicant]
US 8789405B2 · Sugiyama · 2014 [cited by applicant]
US 9017536B2 · Oishi et al. · 2015 [cited by applicant]
US 9080939B2 · Tsai et al. · 2015 [cited by applicant]
US 9429579B2 · Sugiyama et al. · 2016 [cited by applicant]
US 9795328B2 · Taub et al. · 2017 [cited by applicant]
US 9977037B2 · Yoshida et al. · 2018 [cited by applicant]
US 10641724B2 · Ainger et al. · 2020 [cited by applicant]
US 10996187B2 · Lee et al. · 2021 [cited by applicant]
US 11009479B2 · Liu et al. · 2021 [cited by applicant]
US 11111517B2 · Ichiyanagi et al. · 2021 [cited by applicant]
US 11376590B2 · Gurkan et al. · 2022 [cited by applicant]
US 11385244B2 · Shigemitsu et al. · 2022 [cited by applicant]
US 11400452B2 · Jagtiani · 2022 [cited by applicant]
US 11747348B2 · Ko · 2023 [cited by examiner]
US 11852577B2 · Ko · 2023 [cited by examiner]
US 12019082B2 · Ko · 2024 [cited by examiner]
US 20070267361A1 · Tyvoll · 2007 [cited by examiner]
US 20100089774A1 · Manohar et al. · 2010 [cited by applicant]
US 20100145174A1 · Alferness et al. · 2010 [cited by applicant]
US 20100178660A1 · Adamczyk et al. · 2010 [cited by applicant]
US 20150268244A1 · Cho et al. · 2015 [cited by applicant]
US 20180235524A1 · Dunn et al. · 2018 [cited by applicant]
US 20180364186A1 · Watkins et al. · 2018 [cited by applicant]
US 20190232287A1 · Depa et al. · 2019 [cited by applicant]
US 20200101456A1 · Watkins et al. · 2020 [cited by applicant]
US 20200200734A1 · Yu et al. · 2020 [cited by applicant]
US 20210025904A1 · Snodgrass et al. · 2021 [cited by applicant]
US 20210072137A1 · Michel et al. · 2021 [cited by applicant]
US 20210229102A1 · Jagtiani · 2021 [cited by applicant]
US 20210239717A1 · Clarke et al. · 2021 [cited by applicant]
US 20210293693A1 · Bharadwaj et al. · 2021 [cited by applicant]
US 20220065876A1 · Connolly · 2022 [cited by applicant]
US 20220134339A1 · Hayashino et al. · 2022 [cited by applicant]
US 20220187184A1 · Al et al. · 2022 [cited by applicant]
US 20220362779A1 · Jagtiani · 2022 [cited by applicant]
EP 1162449A1 · 2001 [cited by applicant]
EP 2182345B1 · 2013 [cited by applicant]
EP 2568281B1 · 2018 [cited by applicant]
EP 2144057B1 · 2019 [cited by applicant]
EP 2995947B1 · 2020 [cited by applicant]
JP 2002538459A · 2002 [cited by applicant]
JP 2012529033A · 2012 [cited by applicant]
JP 2017521679A · 2017 [cited by applicant]
KR 20050120637A · 2005 [cited by applicant]
KR 20070061042A · 2007 [cited by applicant]
KR 20150108050A · 2015 [cited by applicant]
KR 101584083B1 · 2016 [cited by applicant]
KR 101666847B1 · 2016 [cited by applicant]
KR 101681170B1 · 2016 [cited by applicant]
KR 101802289B1 · 2017 [cited by applicant]
KR 101818368B1 · 2018 [cited by applicant]
KR 101884314B1 · 2018 [cited by applicant]
KR 101885964B1 · 2018 [cited by applicant]
KR 101995253B1 · 2019 [cited by applicant]
KR 102104654B1 · 2020 [cited by applicant]
KR 20200097068A · 2020 [cited by applicant]
KR 102174557B1 · 2020 [cited by applicant]
KR 102281500B1 · 2021 [cited by applicant]
KR 102315843B1 · 2021 [cited by applicant]
KR 102403577B1 · 2022 [cited by applicant]
KR 102439240B1 · 2022 [cited by applicant]
WO 2010137470A1 · 2010 [cited by applicant]
WO 2013153406A1 · 2013 [cited by applicant]
International Search Report and Written Opinion mailed Mar. 17, 2023 for PCT Application No. PCT/KR2022/019905; 6 pages. [cited by applicant]
Tsai , et al., “Impedance measurement system for automatic determination of glycated hemoglobin”, Rev. Sci. Instrum. 89, 065003, https://doi.org/10.1063/1.5025151, Jun. 28, 2018, 10 pages. [cited by applicant]
Cited By (1)
US 12,560,522